// startup autopsy

EmSense

Reading brains to sell ads — a market not ready to listen.

marketfitSlow Death

Years-long decline before final shutdown · Fatal mistake: EmSense bet on neuromarketing adoption before the industry had budget or trust in biometric ad measurement.

Founded	2004
Closed	2012
Country	USA
Sector	Hardware

50%

Key Events Timeline

2004-01-01

FOUNDING

EmSense founded in San Francisco to commercialize EEG-based neuromarketing research.

2007-06-01

PRODUCT LAUNCH

Launched commercial EEG headset platform for measuring consumer brainwave responses to media content.

2010-03-01

FUNDING

Secured final funding round of $13M total; investor appetite for neuromarketing hardware waned sharply afterward.

2012-06-01

SHUTDOWN

EmSense ceased operations after failing to achieve commercial scale in the nascent neuromarketing sector.

2012-01-01

MEDIA_MENTION

# Emsense Technologies. ## Emsense Technologies Overview. ### Emsense Technologies General Information. Developer of a contactless health monitoring system intended to prevent accidents due to loss of control through real-time data to emergency services.. The company offers safety measures monitorin

Full Analysis

Analyst plan

Documented cause

EmSense developed neuromarketing headsets designed to measure consumer brainwave responses to advertisements. The company faced fundamental market adoption challenges: the hardware was expensive to produce and ...

deploy, conducting trials required complex protocols and specialized expertise, and marketing departments lacked sufficient budget allocation for unproven biometric research tools. The business model

Verified lesson

“...”

Unlock full lesson →

€15.6M

Peak valuation

HypeCycle · MoatType · ResearchTags

EmSense raised €13M before emsense bet on neuromarketing adoption before the industry had budget or trust in biometric ad measurement. ended it. See the documented cause, verified lesson and all failure signals.

Unlock full analysis →Create free account

See all plans·Analyst plan — €149/mo